AMPH · Amphastar Pharmaceuticals Inc
United States · RS rating 88 · As of 2026-10-14
| Price | 26.08 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 94 / 94 / 61 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 44 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +37.8% |
| Sales growth Q/Q | -4.5% |
| Distance from 52-week high | +11.3% |
| Market cap (USD) | $935.7M |